EMA: European Medicines Agency and Heads of Medicines Agencies propose measures to make information in application dossiers more transparent

The European Medicines Agency and the Heads of Medicines Agencies (HMA) have released a guidance document on the identification of commercially confidential information and protection of personal data within the structure of the marketing-authorisation dossier for public consultation.